Empirical Finance LLC grew its position in shares of CME Group Inc. (NASDAQ:CME) by 17.6% during the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 4,235 shares of the financial services provider’s stock after buying an additional 634 shares during the quarter. Empirical Finance LLC’s holdings in CME Group were worth $901,000 as of its most recent filing with the Securities & Exchange Commission.
Several other large investors have also recently bought and sold shares of the company. Bank of New York Mellon Corp boosted its holdings in CME Group by 17.8% in the first quarter. Bank of New York Mellon Corp now owns 6,640,423 shares of the financial services provider’s stock worth $1,356,174,000 after purchasing an additional 1,004,852 shares during the last quarter. Parnassus Investments CA boosted its holdings in CME Group by 19.1% in the first quarter. Parnassus Investments CA now owns 5,603,960 shares of the financial services provider’s stock worth $1,144,496,000 after purchasing an additional 899,549 shares during the last quarter. Vontobel Asset Management Inc. boosted its holdings in CME Group by 44.1% in the first quarter. Vontobel Asset Management Inc. now owns 2,829,641 shares of the financial services provider’s stock worth $599,650,000 after purchasing an additional 865,745 shares during the last quarter. Edgewood Management LLC boosted its holdings in CME Group by 6.1% in the first quarter. Edgewood Management LLC now owns 9,680,066 shares of the financial services provider’s stock worth $1,976,960,000 after purchasing an additional 555,111 shares during the last quarter. Finally, Primecap Management Co. CA boosted its holdings in CME Group by 80.6% in the first quarter. Primecap Management Co. CA now owns 1,101,430 shares of the financial services provider’s stock worth $224,945,000 after purchasing an additional 491,700 shares during the last quarter. Hedge funds and other institutional investors own 86.19% of the company’s stock.
In other news, insider Sean Tully sold 5,000 shares of the business’s stock in a transaction dated Tuesday, August 24th. The shares were sold at an average price of $200.20, for a total value of $1,001,000.00. Following the sale, the insider now directly owns 23,479 shares in the company, valued at approximately $4,700,495.80. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, Director Martin J. Gepsman sold 1,000 shares of the business’s stock in a transaction dated Monday, August 23rd. The stock was sold at an average price of $201.37, for a total transaction of $201,370.00. The disclosure for this sale can be found here. Over the last quarter, insiders sold 9,000 shares of company stock worth $1,786,150. 0.30% of the stock is currently owned by insiders.
CME Group (NASDAQ:CME) last announced its quarterly earnings results on Wednesday, July 28th. The financial services provider reported $1.64 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.59 by $0.05. The company had revenue of $1.18 billion for the quarter, compared to the consensus estimate of $1.17 billion. CME Group had a net margin of 41.64% and a return on equity of 8.33%. Equities research analysts expect that CME Group Inc. will post 6.65 earnings per share for the current fiscal year.
The business also recently declared a quarterly dividend, which will be paid on Monday, September 27th. Shareholders of record on Friday, September 10th will be issued a $0.90 dividend. The ex-dividend date is Thursday, September 9th. This represents a $3.60 dividend on an annualized basis and a yield of 1.91%. CME Group’s dividend payout ratio is currently 53.57%.
Several equities research analysts recently issued reports on CME shares. Morgan Stanley raised their target price on shares of CME Group from $228.00 to $229.00 and gave the stock an “equal weight” rating in a report on Thursday, July 1st. Berenberg Bank reiterated a “hold” rating on shares of CME Group in a research note on Wednesday. TheStreet cut shares of CME Group from a “b” rating to a “c+” rating in a research note on Wednesday, August 18th. Finally, Atlantic Securities upgraded shares of CME Group from a “neutral” rating to an “overweight” rating and set a $230.00 price target on the stock in a research note on Tuesday. One investment analyst has rated the stock with a sell rating, eight have assigned a hold rating and six have issued a buy rating to the company’s stock. According to data from MarketBeat.com, CME Group has an average rating of “Hold” and an average target price of $210.83.
About CME Group
CME Group, Inc operates a derivatives marketplace, which offers a range of futures and options products for risk management. Its exchanges offer a range of global benchmark products across all major asset classes based on interest rates, equity indexes, foreign exchange (FX), energy, agricultural commodities and metals.
Featured Story: Most Volatile Stocks
Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CME).
Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.